Wesana granted pre-IND meeting with FDA, currently set for March 11, 2022 Wesana Clinics exhibited a record quarter of billings, new patient visits, telemedicine utilization, overall patient appointments, and ketamine administrations New flagship clinic set to open in late Q1 2022 showcasing the service evolution of Wesana Clinics Strategic restructuring program to realize $1.

Source

Previous articlePharmaTher Announces FDA Approval of Investigational New Drug (IND) Application for Ketamine to Treat ALS
Next articleMydecine to Launch Special Access Support and Supply Program in Canada Expanding Access to Psychedelic-Assisted Psychotherapy For Patients